↓ Skip to main content

Cochrane Database of Systematic Reviews

Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria

Overview of attention for article published in Cochrane database of systematic reviews, October 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news
1 news outlet
twitter
12 tweeters
wikipedia
7 Wikipedia pages

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
211 Mendeley
Title
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
Published in
Cochrane database of systematic reviews, October 2014
DOI 10.1002/14651858.cd010340.pub2
Pubmed ID
Authors

Arturo J Martí-Carvajal, Vidhu Anand, Andrés Felipe Cardona, Ivan Solà

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a chronic, not malignant, disease of the hematopoietic stem cells, associated with significant morbidity and mortality. It is a rare disease with an estimated incidence of 1.3 new cases per one million individuals per year. The treatment of PNH has been largely empirical and symptomatic, with blood transfusions, anticoagulation, and supplementation with folic acid or iron. Eculizumab, a biological agent that inhibits complement cascade, was developed for preventing hemolytic anemia and severe thrombotic episodes.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 211 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 211 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 42 20%
Researcher 24 11%
Student > Bachelor 18 9%
Student > Ph. D. Student 17 8%
Student > Doctoral Student 16 8%
Other 33 16%
Unknown 61 29%
Readers by discipline Count As %
Medicine and Dentistry 71 34%
Nursing and Health Professions 22 10%
Pharmacology, Toxicology and Pharmaceutical Science 9 4%
Psychology 9 4%
Biochemistry, Genetics and Molecular Biology 7 3%
Other 29 14%
Unknown 64 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2020.
All research outputs
#1,475,800
of 20,842,105 outputs
Outputs from Cochrane database of systematic reviews
#3,505
of 12,062 outputs
Outputs of similar age
#20,227
of 253,051 outputs
Outputs of similar age from Cochrane database of systematic reviews
#86
of 248 outputs
Altmetric has tracked 20,842,105 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,062 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.5. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,051 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 248 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.